Grand Pharmaceutical Group Limited (HKG:0512)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.83
+0.08 (1.03%)
At close: Feb 27, 2026
54.44%
Market Cap 27.42B
Revenue (ttm) 11.70B
Net Income (ttm) 2.08B
Shares Out 3.50B
EPS (ttm) 0.59
PE Ratio 13.17
Forward PE 12.94
Dividend 0.26 (3.32%)
Ex-Dividend Date Apr 14, 2025
Volume 5,676,500
Average Volume 3,751,808
Open 7.70
Previous Close 7.75
Day's Range 7.68 - 7.90
52-Week Range 4.97 - 10.20
Beta 0.86
RSI 52.41
Earnings Date Mar 20, 2026

About HKG:0512

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additive... [Read more]

Sector Healthcare
Founded 1995
Employees 12,440
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0512
Full Company Profile

Financial Performance

In 2024, HKG:0512's revenue was 11.64 billion, an increase of 10.59% compared to the previous year's 10.53 billion. Earnings were 2.47 billion, an increase of 31.30%.

Financial Statements

News

There is no news available yet.